M. Livio

Universidade Federal do Maranhão — Brazil

Medicine · Health Sciences

26h-index2.6kcitations69works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(26), Antiplatelet Therapy and Cardiovascular Diseases(26), Eicosanoids and Hypertension Pharmacology(15), Analytical Methods in Pharmaceuticals(7), Coagulation, Bradykinin, Polyphosphates, and Angioedema(7)

Publications69 total

New Insights into Anthelmintic Mechanisms of Action of a Synthetic Peptide: An Ultrastructural and Nanomechanical Approach
Polymers·2021· 9 citedOpen Access
Defective Platelet Aggregation in Response to Platelet-Activating Factor in Uremia Associated With Low Platelet Thromboxane A2 Generation
American Journal of Kidney Diseases·1992· 25 cited
Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
PubMed·1989· 30 cited
Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.
PubMed·1989· 21 citedOpen Access
Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Journal of Pharmacology and Experimental Therapeutics·1989· 19 cited
Metabolism of arachidonic acid in isolated glomeruli from pig kidney
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism·1988· 9 cited
Role of platelet-activating factor in primary hemostasis
American Journal of Physiology-Heart and Circulatory Physiology·1988· 13 cited
Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis
Kidney International·1987· 50 citedOpen Access
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.
Journal of Clinical Investigation·1987· 111 citedOpen Access
Conjugated Estrogens for the Management of Bleeding Associated With Renal Failure
The Journal of Urology·1987· 5 cited
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.
PubMed·1987· 1 cited
Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure
New England Journal of Medicine·1986· 227 cited
MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILURE
The Lancet·1986· 75 cited
Coagulation abnormalities in uremia.
PubMed·1985· 59 cited
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
PubMed·1985· 25 cited
Inhibition of Human Platelet Aggregation by Parathyroid Hormone
American Journal of Nephrology·1985· 25 cited
Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites
European Journal of Pharmacology·1984· 19 cited
The metabolism of arachidonic acid by platelets in nephrotic syndrome
Kidney International·1984· 39 citedOpen Access
Prostanoid-Related Platelet Abnormalities in Renal Disease
Nephrology·1984
Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities
Biochimica et Biophysica Acta (BBA) - General Subjects·1983· 19 cited
page 1 of 4Next →

Frequent Co-authors

Giuseppe Remuzzi(34), Giovanni de Gaetano(20), G Mecca(18), Giovanni de Gaetano(11), Ariela Benigni(11), Maria Benedetta Donati(11), D. Marchesi(10), Chiara Cerletti(9), G Viganò(6), Arrigo Schieppati(6), P. Dodesini(5), Daniela Macconi(5), Silvia Orisio(4), G Rajtar(4), A.E. Cavenaghi(4), Elisabetta Dejana(4), Tullio Bertani(4), Carlo Patrono(3), Rocco Misiani(3), Silvia Villa(3)